nature.com search

Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Nature

Search
My Account Login

nature
search

Search

advanced

where the list of authors contains where the title contains

Refine your results by…

volume

start page / article no.

Filters

Filter By:

Article type

Check one or more article types to show results from those article types only.

Research (3)

Journal

Check one or more journals to show results from those journals only.

Oncogene (7)
Modern Pathology (2)
Laboratory Investigation (1)

Choose more journals

Subject Check one or more subjects to show results from those subjects only.

High-throughput screening (1)
Oncogenesis (1)
Proteomic analysis (1)
Reverse transcription polymerase chain reaction (1)
Sarcoma (1)

Date

Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
In the last year
Last 2 years
Last 5 years

Custom date range

Sort by Relevance

Choose a way to sort results.

Relevance
Date — most recent
Date — oldest first

Loading Filters

Showing 1–10 of 10 results

Loading Filters

Research | 27 March 2018 | Open
Identification of inhibitors regulating cell proliferation and FUS-DDIT3 expression in myxoid liposarcoma using combined DNA, mRNA, and protein analyses
- David Svec
- , Soheila Dolatabadi
- , Christer Thomsen
- , Nicole Cordes
- , Mark Shannon
- , Paul Fitzpatrick
- , Göran Landberg
- , Pierre Åman
- & Anders Ståhlberg
Laboratory Investigation 98 , 957–967

Rights & permissionsfor article Identification of inhibitors regulating cell proliferation and <i>FUS-DDIT3</i> expression in myxoid liposarcoma using combined DNA, mRNA, and protein analyses . Opens in a new window.
27 June 2005
ERK1/2 inhibition increases antiestrogen treatment efficacy by interfering with hypoxia-induced downregulation of ERα: a combination therapy potentially targeting hypoxic and dormant tumor cells
Oncogene 24 , 6835–6841

Rights & permissionsfor article ERK1/2 inhibition increases antiestrogen treatment efficacy by interfering with hypoxia-induced downregulation of ER<i>α</i>: a combination therapy potentially targeting hypoxic and dormant tumor cells . Opens in a new window.
Research | 16 July 2004
Retinoblastoma protein function and p16^INK4a expression in actinic keratosis, squamous cell carcinoma in situ and invasive squamous cell carcinoma of the skin and links between p16^INK4a expression and infiltrative behavior
Modern Pathology 17 , 1464–1474

Rights & permissionsfor article Retinoblastoma protein function and p16<sup>INK4a</sup> expression in actinic keratosis, squamous cell carcinoma <i>in situ</i> and invasive squamous cell carcinoma of the skin and links between p16<sup>INK4a</sup> expression and infiltrative behavior . Opens in a new window.
4 April 2005
ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis
- Sofie Svensson
- , Karin Jirström
- , Lisa Rydén
- , Göran Roos
- , Stefan Emdin
- , Michael C Ostrowski
- & Göran Landberg
Oncogene 24 , 4370–4379

Rights & permissionsfor article ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis . Opens in a new window.
Research | 4 September 2009
Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer
- Annika Jögi
- , Donal J Brennan
- , Lisa Rydén
- , Kristina Magnusson
- , Mårten Fernö
- , Olle Stål
- , Signe Borgquist
- , Mathias Uhlen
- , Göran Landberg
- , Sven Påhlman
- , Fredrik Pontén
- & Karin Jirström
Modern Pathology 22 , 1564–1574

Rights & permissionsfor article Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer . Opens in a new window.
5 July 2002
The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node
- Martin Lodén
- , Maria Stighall
- , Niels Hilmer Nielsen
- , Göran Roos
- , Stefan O Emdin
- , Hanna Östlund
- & Göran Landberg
Oncogene 21 , 4680–4690

Rights & permissionsfor article The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node . Opens in a new window.
27 June 2001
Downregulation of the potential suppressor gene IGFBP-rP1 in human breast cancer is associated with inactivation of the retinoblastoma protein, cyclin E overexpression and increased proliferation in estrogen receptor negative tumors
- Göran Landberg
- , Hanna Östlund
- , Niels Hilmer Nielsen
- , Göran Roos
- , Stefan Emdin
- , Angelika M Burger
- & Arun Seth
Oncogene 20 , 3497–3505

Rights & permissionsfor article Downregulation of the potential suppressor gene IGFBP-rP1 in human breast cancer is associated with inactivation of the retinoblastoma protein, cyclin E overexpression and increased proliferation in estrogen receptor negative tumors . Opens in a new window.
18 October 2004
Regulation of the cyclin A1 protein is associated with its differential subcellular localization in hematopoietic and leukemic cells
Oncogene 23 , 9082–9089

Rights & permissionsfor article Regulation of the cyclin A1 protein is associated with its differential subcellular localization in hematopoietic and leukemic cells . Opens in a new window.
27 April 1999
Cyclin E dependent kinase activity in human breast cancer in relation to cyclin E, p27 and p21 expression and retinoblastoma protein phosphorylation
Oncogene 18 , 2557–2566

Rights & permissionsfor article Cyclin E dependent kinase activity in human breast cancer in relation to cyclin E, p27 and p21 expression and retinoblastoma protein phosphorylation . Opens in a new window.
23 January 1997
Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein
Oncogene 14 , 295–304

Rights & permissionsfor article Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein . Opens in a new window.

Advertisement

Search

Article Search

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

nature.com sitemap

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
Nano
Protocol Exchange
Nature Index

Publish with us

Guide to Authors
Guide to Referees
Editorial policies
Open access
Reprints & permissions

Researcher services

Research data
Language editing
Scientific editing
Nature Masterclasses
Nature Research Academies

Libraries & institutions

Librarian service & tools
Librarian portal
Open research
Recommend to library

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Career development

Nature Careers
Nature Conferences
Nature events

Regional websites

Nature China
Nature India
Nature Japan
Nature Korea
Nature Middle East

Legal & Privacy

Privacy Policy
Use of cookies
Manage cookies/Do not sell my data
Legal notice
Accessibility statement
Terms & Conditions
California Privacy Statement

© 2021 Springer Nature Limited